Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
03/31/2025 | Q1 | $448.8M | -- | -- | $0.26 | -- |
02/20/2025 | Q4 | $414.5M | -- | -- | $0.21 | -- |
11/06/2024 | Q3 | $431.7M | $448.4M | $0.12 | $0.22 | -$0.10 |
08/07/2024 | Q2 | $426.1M | $431.8M | -$0.00 | $0.21 | -$0.21 |
05/01/2024 | Q1 | $425.1M | $416.3M | $0.05 | $0.21 | -$0.16 |
02/20/2024 | Q4 | $393M | $391.3M | $0.02 | $0.13 | -$0.11 |
11/01/2023 | Q3 | -- | -- | $0.01 | $0.15 | -$0.14 |
08/02/2023 | Q2 | -- | -- | -$1.87 | $0.12 | -$1.99 |
05/02/2023 | Q1 | -- | -- | $0.01 | $0.09 | -$0.08 |
02/21/2023 | Q4 | -- | -- | $0.18 | $0.17 | $0.01 |
11/01/2022 | Q3 | -- | -- | -$0.15 | $0.13 | -$0.28 |
08/02/2022 | Q2 | -- | -- | $1.28 | $0.07 | $1.21 |
05/03/2022 | Q1 | -- | -- | -$0.09 | $0.10 | -$0.19 |
02/16/2022 | Q4 | -- | -- | $0.04 | $0.03 | $0.01 |
11/02/2021 | Q3 | -- | -- | -$0.10 | $0.10 | -$0.20 |
08/03/2021 | Q2 | -- | -- | $0.01 | $0.19 | -$0.18 |
05/04/2021 | Q1 | -- | -- | $0.25 | $0.12 | $0.13 |
02/16/2021 | Q4 | -- | -- | -$0.21 | $0.28 | -$0.49 |
11/03/2020 | Q3 | -- | -- | $0.23 | $0.28 | -$0.05 |
08/05/2020 | Q2 | -- | -- | -$0.27 | -$0.11 | -$0.16 |
05/07/2020 | Q1 | -- | -- | $0.02 | $0.14 | -$0.12 |
02/18/2020 | Q4 | -- | -- | $0.15 | $0.29 | -$0.14 |
11/05/2019 | Q3 | -- | -- | $0.27 | $0.40 | -$0.13 |
08/06/2019 | Q2 | -- | -- | $0.30 | $0.37 | -$0.07 |
05/07/2019 | Q1 | -- | -- | $0.70 | $0.77 | -$0.07 |
02/19/2019 | Q4 | -- | -- | $0.62 | $0.59 | $0.03 |
11/06/2018 | Q3 | -- | -- | $0.70 | $0.70 | -$0.00 |
08/07/2018 | Q2 | -- | -- | $0.82 | $0.80 | $0.02 |
05/08/2018 | Q1 | -- | -- | $0.82 | $0.76 | $0.06 |
02/20/2018 | Q4 | -- | -- | $0.63 | $0.53 | $0.10 |
10/31/2017 | Q3 | -- | -- | $0.57 | $0.50 | $0.07 |
08/08/2017 | Q2 | -- | -- | $0.65 | $0.58 | $0.07 |
05/09/2017 | Q1 | -- | -- | $0.62 | $0.59 | $0.03 |
02/21/2017 | Q4 | -- | -- | $0.45 | $0.48 | -$0.03 |
11/03/2016 | Q3 | -- | -- | $0.50 | $0.53 | -$0.03 |
08/03/2016 | Q2 | -- | -- | $0.55 | $0.56 | -$0.01 |
05/03/2016 | Q1 | -- | -- | $0.55 | $0.50 | $0.05 |
02/17/2016 | Q4 | -- | -- | $0.40 | $0.41 | -$0.01 |
11/05/2015 | Q3 | -- | -- | $0.42 | $0.44 | -$0.02 |
08/04/2015 | Q2 | -- | -- | $0.46 | $0.45 | $0.01 |
05/05/2015 | Q1 | -- | -- | $0.42 | $0.41 | $0.01 |
Openlane reported $448.4M worth of top line sales in its most recent quarter.
Openlane announced earnings per share of $0.12 which represents a miss of analyst forecast a $0.22 per share.
Openlane reported $196.4M that represents $1.80 per share over the last quarter.
Openlane's earnings are forecast to decrease from -$1.82 per share to $0.84 per share next year representing a decrease of -47.92%.
Openlane's next earnings date is February 20, 2025.
Signup to receive the latest stock alerts
2024 was another banner year for the US stock market,…
Carlos Slim made a splash in a surprising sector last…
There is a lot of humdrum in the market about…
Market Cap: $3.7T
P/E Ratio: 40x
Market Cap: $3.4T
P/E Ratio: 116x
Market Cap: $3.1T
P/E Ratio: 35x
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Banco Macro SA [BMA] is up 0.88% over the past day.
Agrify [AGFY] is down 5.86% over the past day.